| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/01/1998 | US5800988 Cdna libraries with nucleotide sequences coded for immunoglobulins with polypeptide chains |
| 09/01/1998 | US5800539 Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
| 09/01/1998 | CA2086874E Methods for administration of taxol |
| 09/01/1998 | CA1340023C Tetrapyrrole aminocarboxylic acids |
| 09/01/1998 | CA1340021C Anthracycline derivatives having cytostatic activity |
| 09/01/1998 | CA1340018C Monoclonal antibodies reactive with cachetin |
| 08/27/1998 | WO1998037194A1 Ell2, a member of an ell family of rna polymerase ii elongation factors |
| 08/27/1998 | WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 08/27/1998 | WO1998037190A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
| 08/27/1998 | WO1998037098A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 08/27/1998 | WO1998037094A2 Secreted proteins and polynucleotides encoding them |
| 08/27/1998 | WO1998037091A2 Modified retinoblastoma tumor suppressor proteins |
| 08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
| 08/27/1998 | WO1998037057A1 Preparation of acid amides and metallisation of compounds |
| 08/27/1998 | WO1998036777A1 Site-specific drug delivery |
| 08/27/1998 | WO1998036776A2 Gel delivery vehicles for anticellular proliferative agents |
| 08/27/1998 | WO1998036765A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| 08/27/1998 | WO1998036761A1 Anti-proliferative preparations |
| 08/27/1998 | WO1998036754A1 Use of 9,10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol |
| 08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
| 08/27/1998 | WO1998017814A3 Gene expression and delivery systems and uses |
| 08/27/1998 | WO1998013499A3 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors |
| 08/27/1998 | WO1998006437A3 Compositions and methods for polynucleotide delivery |
| 08/27/1998 | DE19708454A1 Die Proliferation von Zellen inhibierendes Peptid und dessen Verwendung The proliferation of cells inhibiting peptide and use thereof |
| 08/27/1998 | CA2742641A1 Compounds for immunotherapy of prostate cancer and methods for their use |
| 08/27/1998 | CA2283090A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio |
| 08/27/1998 | CA2282504A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| 08/27/1998 | CA2282086A1 Use of 9, 10-secocholesta-5,7,10(19)-triene-1,3-diol, or alfacacidol |
| 08/27/1998 | CA2281919A1 Gel delivery vehicles for anticellular proliferative agents |
| 08/27/1998 | CA2281899A1 Modified retinoblastoma tumor suppressor proteins |
| 08/27/1998 | CA2281493A1 Site-specific drug delivery |
| 08/27/1998 | CA2281059A1 Secreted proteins and polynucleotides encoding them |
| 08/27/1998 | CA2251645A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 08/26/1998 | EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 08/26/1998 | EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes |
| 08/26/1998 | EP0859860A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 08/26/1998 | EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 08/26/1998 | EP0859639A1 Methods for treating cancers and restenosis with p21 |
| 08/26/1998 | EP0859631A1 Treatment or prevention of neoplastic and infectious diseases with heat shock/stress proteins |
| 08/26/1998 | EP0859630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer |
| 08/26/1998 | EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 08/26/1998 | EP0859627A1 Mimicking peptides in cancer therapy |
| 08/26/1998 | EP0859624A1 GnRH/REDUCED PSEUDOMONAS EXOTOXIN CONJUGATES |
| 08/26/1998 | EP0859622A1 Extracts of shark cartilage |
| 08/26/1998 | EP0764155B1 Taxoids, preparation and pharmaceutical compositions containing them |
| 08/26/1998 | EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists |
| 08/26/1998 | EP0686641B1 2'-deoxy-5-fluorouridine derivative, pharmaceutically acceptable salt thereof, process for producing the same, and antitumor drug |
| 08/26/1998 | EP0664708B1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent |
| 08/26/1998 | CN1191572A Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 08/26/1998 | CN1191568A Gene switch comprising ecdysone receptor |
| 08/26/1998 | CN1191567A Macrophage activating factors derived from cloned vitamin D binding protein |
| 08/26/1998 | CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists |
| 08/26/1998 | CN1191491A 结缔组织生长因子 Connective tissue growth factor |
| 08/26/1998 | CN1191487A Method for inhibiting vascular smooth muscle cell migration |
| 08/26/1998 | CN1191485A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substd. amino 1, 2, 3-triazoles |
| 08/26/1998 | CN1191482A Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substd.) hydrazines |
| 08/26/1998 | CN1039586C Method for preparing organic salts of N, N'-diacetyl cystine |
| 08/26/1998 | CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence |
| 08/25/1998 | US5798491 Multi-mechanistic chemical cleavage using certain metal complexes |
| 08/25/1998 | US5798448 AL-1 neurotrophic factor antibodies |
| 08/25/1998 | US5798351 Useful for inhibiting bone loss, lowering seum cholesterol levels and treating hormone dependent mammalian breast and uterine cancer |
| 08/25/1998 | US5798345 Method of inhibiting the hyperproliferation of malignant cells |
| 08/25/1998 | US5798257 Nucleic acid encoding human MTS-1 protein |
| 08/25/1998 | US5798229 Bispecific molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 08/25/1998 | US5798228 Recombinant production of dog and horse type I interferons |
| 08/25/1998 | US5798213 Monoclonal antibodies |
| 08/25/1998 | US5798100 Multi-stage cascade boosting vaccine |
| 08/25/1998 | US5798097 Immunogobulin conjugates |
| 08/25/1998 | CA2122479C Risedronate delayed-release compositions |
| 08/25/1998 | CA2087543C Heterocyclic compounds |
| 08/25/1998 | CA1340012C Peptide determinant associated with immunity |
| 08/24/1998 | CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor |
| 08/20/1998 | WO1998036070A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION |
| 08/20/1998 | WO1998036069A1 Novel human mago nashi protein |
| 08/20/1998 | WO1998036068A2 Human p24 vesicle proteins |
| 08/20/1998 | WO1998036062A1 Neural cell adhesion molecule splicing variants |
| 08/20/1998 | WO1998035985A1 Protein markers for lung cancer and use thereof |
| 08/20/1998 | WO1998035983A1 The proliferation of cell-inhibiting peptide and its use |
| 08/20/1998 | WO1998035981A1 Prevention and treatment of hepatocellular cancer |
| 08/20/1998 | WO1998035969A1 Alkynyl-substituted camptothecins and process for their preparation |
| 08/20/1998 | WO1998035958A1 Phthalazines with angiogenesis inhibiting activity |
| 08/20/1998 | WO1998035949A1 Bicyclic amino acids |
| 08/20/1998 | WO1998035940A1 Highly lipophilic camptothecin derivatives |
| 08/20/1998 | WO1998035704A1 Targeted therapeutic delivery of vitamin d compounds |
| 08/20/1998 | WO1998035698A1 Remedies for lymphocytic tumors |
| 08/20/1998 | WO1998035693A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
| 08/20/1998 | WO1998035682A1 Agent for hormonal contraception and/or treatment and/or prophylaxis of mammary glands with three hormone components |
| 08/20/1998 | WO1998035562A1 Polynucleotide vaccine formulations |
| 08/20/1998 | WO1998035554A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 08/20/1998 | WO1998014596A3 Disease associated protein tyrosine phosphatases |
| 08/20/1998 | DE19712659C1 Use of Alchemilla vulgaris extract as angiogenesis inhibitor |
| 08/20/1998 | DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids |
| 08/20/1998 | CA2282683A1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 08/20/1998 | CA2281033A1 The proliferation of cell-inhibiting peptide and its use |
| 08/20/1998 | CA2280896A1 Novel human mago nashi protein |
| 08/20/1998 | CA2280839A1 Polynucleotide vaccine formulations |
| 08/20/1998 | CA2280634A1 Human p24 vesicle proteins |
| 08/20/1998 | CA2279590A1 Targeted therapeutic delivery of vitamin d compounds |
| 08/20/1998 | CA2243984A1 Neural cell adhesion molecule splicing variants |
| 08/19/1998 | EP0859053A1 Novel G-protein coupled receptor (HTADX50) |